DU
BVS icon

Delphia (USA)’s Bioventus BVS Stock Holding History

Delphia (USA)’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,643
Closed -$33K – 270
2022
Q4 		$33K Buy
+12,643
New +$55.2K 0.04% 271

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Delphia (USA)'s BVS Position: Q1 2023 in Review

Delphia (USA) sold out of Bioventus (BVS) in Q1 2023, closing a stake of 12,643 shares — an estimated $33K sold.

Delphia (USA) first reported a position in BVS in Q4 2022 and held it in 1 quarter. The position peaked at $33K in Q4 2022. 71 funds tracked by Wall St. Rank hold BVS as of Q1 2023.

  • Delphia (USA) reported no remaining Bioventus position as of Q1 2023 after selling out during the quarter.
  • Delphia (USA) sold 12,643 Bioventus shares in Q1 2023, an estimated $33K.
  • Delphia (USA) first reported a position in Bioventus in Q4 2022 and held it in 1 quarter.
  • Delphia (USA)'s Bioventus position peaked at $33K in Q4 2022.
  • 71 funds tracked by Wall St. Rank held Bioventus as of Q1 2023.

Based on Delphia (USA)'s 13F filing for Q1 2023, filed 15 May 2023.